The production of high levels of IFNγ can further orchestrate an antitumor milieu and create a feedback loop between IL-12 and IFNγ, increasing expression of major histocompatibility class I and II molecules (MHC-I/MHC-II) and tumor antigen presentation and recognition. This evidence concerns the gene IFNG and neoplasm.